North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028

North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 – Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

Send Enquiry
Item ID: BMIRE00028875 Category: Tags: , ,

$2,100$3,500

Description

The North America enteral and parenteral medical nutrition market is expected to grow from US$ 8,049.98 million in 2023 to US$ 11,030.78 million by 2028. It is estimated to grow at a CAGR of 6.5% from 2023 to 2028.
Rise in Prevalence of Gastrointestinal Diseases Fuels North America Enteral and Parenteral Medical Nutrition Market
Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancers are a few examples of gastrointestinal diseases.
Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; China (911,405) and the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn’s disease and ulcerative colitis are two of the commonly diagnosed IBDs. Crohn’s disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled “Understanding Short Bowel Syndrome: Current Status and Future Perspectives,” published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence was ~30 cases per million in the US.
Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirement, which can be a result of the disease itself. Thus, medical nutrition is recommended for gastrointestinal disease patients as these patients cannot ingest food. Thus, the enteral and parenteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to food nutrition intake directly through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Some people may not show compatibility toward tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs due to diseases, such as cancer and chronic diseases affecting the gastrointestinal tract. This type of nutrition is the cornerstone of therapy for most patients with severe SBS. Therefore, the elevating prevalence of gastrointestinal diseases drives the growth of the North America enteral and parenteral medical nutrition market.
North America Enteral and Parenteral Medical Nutrition Market Overview
The enteral and parenteral medical nutrition market in North America has been segmented into the US and Canada. The US held a larger share of the market in 2022. The rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral and parenteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions further contributes to the market growth.
North America Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

North America Enteral and Parenteral Medical Nutrition Market Segmentation
The North America enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.
Based on indication, the North America enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.
Based on nutrition type, the North America enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the North America enteral and parenteral medical nutrition market in 2023.
Based on form, the North America enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.
Based on product type, the North America enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.
Based on route of administration, the North America enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.
Based on age group, the North America enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.
Based on distribution channel, the North America enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023
Based on country, the North America enteral and parenteral medical nutrition market is segmented into the US and Canada. The US dominated the share of the North America enteral and parenteral medical nutrition market in 2023.
Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Medica Nutrition Inc; Medtrition Inc; Nestle SA; Nutricia International BV; and Nutrisens SAS are some of the leading companies operating in the North America enteral and parenteral medical nutrition market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 6.5% CAGR, the North America Enteral and Parenteral Medical Nutrition Market is speculated to be worth US$ 11,030.78 million by 2028, saysthe research team
According tothe research team’ research, the North America enteral and parenteral medical nutrition market was valued at US$ 8,049.98 million in 2023 and is expected to reach US$ 11,030.78 million by 2028, registering a CAGR of 6.5% from 2023 to 2028. Rise in prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births are the critical factors attributed to the North America enteral and parenteral medical nutrition market expansion.
Product recalls caused by issues with artwork and packaging are an ongoing problem for many consumer and pharmaceutical companies. The problems can come from several areas, such as non-standardized bills of material, translation mistakes, typos, and poor proofreading, expired digital assets, poor printing quality, third-party artwork suppliers, and printing shops. Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had stunted growth and development due to a chronic lack of nutrient-rich food in their diets, and 45 million were wasted (too thin for height). ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data of the United Nations International Children’s Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021. Similarly, as per a study titled “A multi-center survey on hospital malnutrition,” published in 2021, ~33% of hospital patients in the US were either malnourished or at nutritional risk, and nearly 11-45% of patients in hospitals and home care settings in England suffered from malnutrition. Nutritional support delivered through enteral & parenteral means, depending on the need, is an important and appropriate way of treating most malnutrition cases. Thus, the huge burden of malnutrition in children and adults drives the demand for enteral and parenteral nutrition formulae and products.
Preterm birth refers to a baby being born too early, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm birth (more than 1 in 10 births) were reported worldwide in 2020. According to the Centers for Disease Control and Prevention (CDC) data, preterm birth in the US accounted for 10% of all births in 2020 and reached 10.5% in 2021, recording a yearly rise of 4%. Per the same source, the rate of preterm birth among African American women (14.8%) was about 50% higher than the rate reported among white or Hispanic women (9.5% and 10.2%, respectively). A large number of premature babies suffer from low weight and undeveloped immunity, which puts their life at risk. Most medical guidelines advise enteral nutrition for supporting the optimal growth of preterm infants if they are unable to drink, suck, swallow, and breathe, also parenteral nutrition are preferred in such babies due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. Hence, with the high number of preterm births, the demand for enteral and parenteral medical nutrition is on the rise in the North America.
On the contrary, mechanical, gastrointestinal, and metabolic complications associated with enteral and parenteral feeding systems, and limitations related to catheter placement hampers the North America Enteral and Parenteral Medical Nutrition Market.
Based on indication, the North America enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held 29.9% share of North America Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 2,406.72 million. It is projected to garner US$ 3,330.47 million by 2028 to expand at 6.7% CAGR during 2023-2028.
Based on nutrition type, the North America enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held 79.0% share of North America Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 6,356.59 million. It is projected to garner US$ 8,651.86 million by 2028 to expand at 6.4% CAGR during 2023-2028.
Based on form, the North America enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held 53.5% share of North America Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 4,303.19 million. It is projected to garner US$ 5,917.77 million by 2028 to expand at 6.6% CAGR during 2023-2028.
Based on product type, the North America enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held 57.7% share of North America Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 4,644.46 million. It is projected to garner US$ 6,419.06 million by 2028 to expand at 6.7% CAGR during 2023-2028.
Based on route of administration, the North America enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held 43.8% share of North America Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 3,524.29 million. It is projected to garner US$ 4,792.65 million by 2028 to expand at 6.3% CAGR during 2023-2028.
Based on age group, the North America enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held 39.4% share of North America Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 3,173.56 million. It is projected to garner US$ 4,364.34 million by 2028 to expand at 6.6% CAGR during 2023-2028.
Based on distribution channel, the North America enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held 40.6% share of North America Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 3,269.34 million. It is projected to garner US$ 4,430.03 million by 2028 to expand at 6.3% CAGR during 2023-2028.
Based on country, the North America enteral and parenteral medical nutrition market has been categorized into the US and Canada. Our regional analysis states that the US captured 81.6% share of North America Enteral and Parenteral Medical Nutrition Market in 2023. It was assessed at US$ 6,569.81 million in 2023 and is likely to hit US$ 9,061.03 million by 2028, exhibiting a CAGR of 6.6% during the forecast period.
Key players operating in the North America enteral and parenteral medical nutrition market are Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Medica Nutrition Inc; Medtrition Inc; Nestle SA; Nutricia International BV; and Nutrisens SAS, among others.
November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby’s health and development, including the developing immune system, digestive system and brain.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Enteral and Parenteral Medical Nutrition Market – By Indication
1.3.2 North America Enteral and Parenteral Medical Nutrition Market – By Nutrition Type
1.3.3 North America Enteral and Parenteral Medical Nutrition Market – By Form
1.3.4 North America Enteral and Parenteral Medical Nutrition Market – By Product Type
1.3.5 North America Enteral and Parenteral Medical Nutrition Market – By Route of Administration
1.3.6 North America Enteral and Parenteral Medical Nutrition Market – By Age Group
1.3.7 North America Enteral and Parenteral Medical Nutrition Market – By Distribution Channel
1.3.8 North America Enteral and Parenteral Medical Nutrition Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Enteral and Parenteral Medical Nutrition Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
4.4 Energy Content Analysis
4.4.1 Lower than 1.5 kcal/ml
4.4.2 Equals to 1.5 kcal/ml
4.4.3 Lower than 2kcal/ml:
4.4.4 Equal to or Higher than 2kcal/ml:
5. North America Enteral and Parenteral Medical Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Increasing Cases of Malnutrition and Premature Births
5.2 Market Restraints
5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
5.3 Market Opportunities
5.3.1 Growing Strategic Initiatives by Companies
5.4 Future Trends
5.4.1 Specific Formulations and Plant-Based Nutrition Products
5.5 Impact Analysis
6. Enteral and Parenteral Medical Nutrition Market – North America Analysis
6.1 North America Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis
7. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Indication
7.1 Overview
7.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
7.3 Elderly
7.3.1 Overview
7.3.2 Elderly: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
7.4 Gastrointestinal Disorders
7.4.1 Overview
7.4.2 Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
7.4.3 Inflammatory Bowel Disease
7.4.3.1 Overview
7.4.3.2 IBD: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.2.1 North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
7.4.4 Irritable Bowel Syndrome
7.4.4.1 Overview
7.4.4.2 IBS: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.2.1 North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
7.5 Diabetes
7.5.1 Overview
7.5.2 Diabetes: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
7.6 Cancer
7.6.1 Overview
7.6.2 Cancer: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
7.7 Respiratory Disorders
7.7.1 Overview
7.7.2 Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.7.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
7.8 Alzheimer’s Disease
7.8.1 Overview
7.8.2 Alzheimer’s Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
7.9 Dementia
7.9.1 Overview
7.9.2 Dementia: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.9.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
7.10 Renal Disease
7.10.1 Overview
7.10.2 Renal Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.10.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
7.11 Liver Failure
7.11.1 Overview
7.11.2 Liver Failure: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.11.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
7.12 Post COVID-19
7.12.1 Overview
7.12.2 Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.12.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
7.13 Other Indications
7.13.1 Overview
7.13.2 Other Indications: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.13.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
8. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Nutrition Type
8.1 Overview
8.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
8.3 Supplemental
8.3.1 Overview
8.3.2 Supplemental: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sole Source
8.4.1 Overview
8.4.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Form
9.1 Overview
9.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
9.3 Liquid
9.3.1 Overview
9.3.2 Liquid: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Powder
9.4.1 Overview
9.4.2 Powder: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Semi-Solid
9.5.1 Overview
9.5.2 Semi-Solid: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Product Type
10.1 Overview
10.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
10.3 General
10.3.1 Overview
10.3.2 General: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Disease Specific
10.4.1 Overview
10.4.2 Disease Specific: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Route of Administration
11.1 Overview
11.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
11.3 Oral
11.3.1 Overview
11.3.2 Oral: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Tube Feed
11.4.1 Overview
11.4.2 Tube Feed: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Parenteral
11.5.1 Overview
11.5.2 Parenteral: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Age Group
12.1 Overview
12.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
12.3 Above 60 Years
12.3.1 Overview
12.3.2 Above 60 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12.4-60 Years
12.4.1 Overview
12.4.2-60 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12.5 3-18 Years
12.5.1 Overview
12.5.2 3-18 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12.6 Below 3 Years
12.6.1 Overview
12.6.2 Below 3 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Distribution Channel
13.1 Overview
13.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
13.3 Hospital Pharmacies
13.3.1 Overview
13.3.2 Hospital Pharmacies: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.4 Retail Stores
13.4.1 Overview
13.4.2 Retail Stores: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.5 E-Commerce
13.5.1 Overview
13.5.2 E-Commerce: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.6 Others
13.6.1 Overview
13.6.2 Others: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – Country Analysis
14.1 Overview
14.1.1.1 US: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.1.1 Overview
14.1.1.1.2 US: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.1.3 US: North America Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.1.3.1 US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.1.3.2 US: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form
14.1.1.1.3.3 US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.1.3.3.1 US: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.1.3.3.2 US: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.1.3.3.3 US: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.1.3.4 US: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.1.3.5 US: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.1.3.6 US: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.1.3.7 US: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.1.3.8 US: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.1.3.9 US: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.1.3.10 US: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.1.3.11 US: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.1.3.12 US: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.1.4 US: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.1.5 US: North America Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.1.6 US: North America Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.1.7 US: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.1.8 US: North America Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.1.9 US: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
14.1.1.2 Canada: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.2.1 Overview
14.1.1.2.2 Canada: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.2.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.2.3.1 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.2.3.2 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3.1 Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3.2 Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.2.3.4 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.2.3.5 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.2.3.6 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.2.3.7 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.2.3.8 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.2.3.9 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.2.3.10 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.2.3.11 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.2.3.12 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.2.4 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.2.5 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.2.6 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.2.7 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.2.8 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.2.9 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
15. North America Enteral and Parenteral Medical Nutrition Market – Industry Landscape
15.1 Overview
15.2 Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
15.3 Inorganic Growth Strategies
15.3.1 Overview
15.4 Organic Growth Strategies
15.4.1 Overview
16. Company Profiles
16.1 Abbott Laboratories
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Nestle SA
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Nutricia International BV
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Medtrition Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Fresenius Kabi AG
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 B. Braun SE
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Nutrisens SAS
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Baxter International Inc
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Medica Nutrition Inc
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
17. Appendix
17.1 About
17.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Enteral and Parenteral Medical Nutrition Market, For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 7. North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 8. North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 9. North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 10. North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 11. North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 12. North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 13. North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 14. North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 15. US: North America Enteral and Parenteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 17. US: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 18. US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 19. US: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 20. US: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 21. US: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 22. US: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 23. US: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 24. US: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 25. US: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 26. US: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 27. US: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 28. US: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 29. US: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 30. US: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 31. US: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. US: North America Enteral and Parenteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (US$ Million)
Table 33. US: North America Enteral and Parenteral Medical Nutrition Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. US: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 35. US: North America Enteral and Parenteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 36. US: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 37. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 38. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 39. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 40. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 41. Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 42. Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 43. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 44. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 45. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 46. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 47. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 48. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 49. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 50. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 51. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 52. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 53. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 54. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (US$ Million)
Table 55. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 57. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 58. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 59. Recent Inorganic Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
Table 60. Recent Organic Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
Table 61. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Enteral and Parenteral Medical Nutrition Market Segmentation
Figure 2. North America Enteral and Parenteral Medical Nutrition Market, By Country
Figure 3. North America Enteral and Parenteral Medical Nutrition Market Overview
Figure 4. Elderly Segment Held Largest Share of Indication Segment in North America Enteral and Parenteral Medical Nutrition Market
Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. North America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis
Figure 10. North America Enteral and Parenteral Medical Nutrition Market- Revenue Forecast and Analysis – 2020- 2028
Figure 11. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
Figure 12. Elderly: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. IBD: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IBS: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Diabetes: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Alzheimer’s Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Dementia: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Renal Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Liver Failure: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Other Indications: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
Figure 27. Supplemental: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
Figure 30. Liquid: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Powder: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Semi-Solid: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
Figure 34. General: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Disease Specific: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
Figure 37. Oral: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Tube Feed: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Parenteral: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
Figure 41. Above 60 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42.-60 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. 3-18 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Below 3 Years: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
Figure 46. Hospital Pharmacies: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Retail Stores: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. E-Commerce: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Others: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. North America Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. North America Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 52. US: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Canada: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market

The List of Companies – North America Enteral and Parenteral Medical Nutrition Market

– Abbott Laboratories
– B. Braun SE
– Baxter International Inc
– Fresenius Kabi AG
– Medica Nutrition Inc
– Medtrition Inc
– Nestle SA
– Nutricia International BV
– Nutrisens SAS

Reviews

There are no reviews yet.

Be the first to review “North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028”